In human scalp areas affected by alopecia areata, an excessive expression of IL-1β is detected particularly at the early stages of the disease, while susceptibility to the disease and severity are determined by polymorphisms of the IL-1-receptor antagonist and IL-1a. Here, IL1A is linked to alopecia areata.